G9649 – Psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi))
HCPCS Level II code · G codes: Procedures / Professional Services (Temporary)
HCPCS codeG9649
- Long description
- Psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi))
- Short description
- Psor as doc spc bm
- Pricing indicator
00Not separately priced by Part B (bundled, not covered or Part A only)- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
Z2Undefined codes- Added
- January 1, 2016
- Last change
- January 1, 2019 – No change
Frequently asked questions
What is HCPCS code G9649?
G9649 is a HCPCS Level II code for psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi)).
Does Medicare cover G9649?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby G codes
- G9641 – Major amputation or open surgical bypass required within 48 hours of the index endovascular lower extremity revascularization procedure
- G9642 – Current smoker (e.g., cigarette, cigar, pipe, e-cigarette or marijuana)
- G9643 – Elective surgery
- G9644 – Patients who abstained from smoking prior to anesthesia on the day of surgery or procedure
- G9645 – Patients who did not abstain from smoking prior to anesthesia on the day of surgery or procedure
- G9646 – Patients with 90 day mrs score of 0 to 2
- G9647 – Patients in whom mrs score could not be obtained at 90 day follow-up
- G9648 – Patients with 90 day mrs score greater than 2
- G9650 – Documentation that the patient declined therapy change or has documented contraindications (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi
- G9651 – Psoriasis assessment tool documented not meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi)) or psoriasis assessment tool not documented
- G9652 – Patient has been treated with a systemic or biologic medication for psoriasis for at least six months
- G9653 – Patient has not been treated with a systemic or biologic medication for psoriasis for at least six months
- G9654 – Monitored anesthesia care (mac)
- G9655 – A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is used
- G9656 – Patient transferred directly from anesthetizing location to pacu or other non-icu location
- G9657 – Transfer of care during an anesthetic or to the intensive care unit
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.